NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Gains from Sales and Divestitures (2012 - 2013)

Updated

NovelStem International (NSTM) reported Gains from Sales and Divestitures of $1.00 for Q2 2021.

Analysis

NovelStem International (NSTM) Gains from Sales and Divestitures (2012 - 2013) Analysis & Trends

For FY2012, NovelStem International posted Gains from Sales and Divestitures of $689,762.

  • By year, Gains from Sales and Divestitures came in at -$72,144 in FY2010 and -$820.00 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 NovelStem International 493,324.54 346,279.54 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 1.00
Mar 31, 2013 -1,069.00
Sep 30, 2012 40,547.00
API Access

NovelStem International Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NSTM&period=max&api_key=YOUR_API_KEY